Five wearable devices that monitor patients with Parkinson's disease as they go about their lives have been given a provisional recommendation from NICE, making them available via the NHS w
Akili’s new era as a subsidiary of Virtual Therapeutics will start with FDA approval of its digital therapeutic for attention-deficit hyperactivity disorder (ADHD) in adults, a key part of